These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 26564691)
21. Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study. Tegegne AS; Ndlovu P; Zewotir T BMC Infect Dis; 2018 Feb; 18(1):83. PubMed ID: 29458343 [TBL] [Abstract][Full Text] [Related]
22. Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART. Guaraldi G; Murri R; Orlando G; Orlandi E; Sterrantino G; Borderi M; Grosso C; Cattelan AM; Nardini G; Beghetto B; Antinori A; Esposito R; Wu AW HIV Clin Trials; 2003; 4(2):99-106. PubMed ID: 12671777 [TBL] [Abstract][Full Text] [Related]
23. [Factors associated with adherence of highly active antiretroviral therapy among 386 HIV/AIDS patients in 3 provinces of China]. Zhao WY; Yu HL; Ye SD; Wu YS; Wang M; Lao YF; He SH; Yang Y; Ling XM; Liu ZF Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):334-8. PubMed ID: 27029365 [TBL] [Abstract][Full Text] [Related]
24. [Effect of highly active anti-retroviral therapy on reducing HIV/AIDS related death in Hebei, 1989-2013]. Chen S; Ma L; Lu X; Li Y; Wang W; Wang Y; Zhao C; Zhang Y; Zhao H Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):460-4. PubMed ID: 26080634 [TBL] [Abstract][Full Text] [Related]
25. Determinants of Adherence among Patients on Highly Active Anti-Retroviral Therapy in Lagos State, Nigeria. Adeniran A; Odugbemi BA; Fisher OO; Atilola O West Afr J Med; 2021 Jun; 38(6):520-525. PubMed ID: 34174178 [TBL] [Abstract][Full Text] [Related]
26. The association between combination antiretroviral adherence and AIDS-defining conditions at HIV diagnosis. Abara WE; Xu J; Adekeye OA; Rust G AIDS Care; 2016 Aug; 28(8):1013-7. PubMed ID: 26886075 [TBL] [Abstract][Full Text] [Related]
27. Factors associated with non-adherence to antiretroviral therapy in adults with AIDS in the first six months of treatment in Salvador, Bahia State, Brazil. Silva JA; Dourado I; Brito AM; Silva CA Cad Saude Publica; 2015 Jun; 31(6):1188-98. PubMed ID: 26200367 [TBL] [Abstract][Full Text] [Related]
28. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903 [TBL] [Abstract][Full Text] [Related]
29. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon. Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756 [TBL] [Abstract][Full Text] [Related]
30. Supporting adherence to highly active antiretroviral therapy and protected sex among people living with HIV/AIDS: the role of patient-provider communication in Rio de Janeiro, Brazil. Fehringer J; Bastos FI; Massard E; Maia L; Pilotto JH; Kerrigan D AIDS Patient Care STDS; 2006 Sep; 20(9):637-48. PubMed ID: 16987050 [TBL] [Abstract][Full Text] [Related]
31. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya. Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092 [TBL] [Abstract][Full Text] [Related]
32. [Analysis of survival and influencing factors of HIV/AIDS patients in Tianjin, 2004-2014]. Liu ZQ; Zhou N; Bai JY; Guo Y; Yu MH Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Mar; 38(3):369-373. PubMed ID: 28329942 [No Abstract] [Full Text] [Related]
33. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS. Proctor VE; Tesfa A; Tompkins DC AIDS Patient Care STDS; 1999 Sep; 13(9):535-44. PubMed ID: 10813033 [TBL] [Abstract][Full Text] [Related]
34. [Prevalence of depression and related factors in 180 HIV/AIDS patients receiving highly active antiretroviral therapy]. Jiang Y; Wang M; Wei XQ; He JM; Guo TS; Huang GQ; Wu YQ; Zhang PF; Qi H; Chen X Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):638-42. PubMed ID: 27188353 [TBL] [Abstract][Full Text] [Related]
35. Adherence to combined Antiretroviral therapy (cART) among people living with HIV/AIDS in a Tertiary Hospital in Ilorin, Nigeria. Anyaike C; Atoyebi OA; Musa OI; Bolarinwa OA; Durowade KA; Ogundiran A; Babatunde OA Pan Afr Med J; 2019; 32():10. PubMed ID: 31080546 [TBL] [Abstract][Full Text] [Related]
36. A cluster randomised controlled trial protocol of an adapted intervention for alcohol use disorders in people living with HIV and AIDS: impact on alcohol use, general functional ability, quality of life and adherence to HAART. Madhombiro M; Dube-Marimbe B; Dube M; Chibanda D; Zunza M; Rusakaniko S; Stewart D; Seedat S BMC Psychiatry; 2017 Jan; 17(1):44. PubMed ID: 28129756 [TBL] [Abstract][Full Text] [Related]
37. Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals. Murri R; Guaraldi G; Lupoli P; Crisafulli R; Marcotullio S; von Schloesser F; Wu AW AIDS Patient Care STDS; 2009 Jan; 23(1):35-9. PubMed ID: 19183079 [TBL] [Abstract][Full Text] [Related]
38. Factors influencing adherence to anti-retroviral therapy in amazonian indigenous people living with HIV/AIDS. Valenzuela-Oré F; Angulo-Bazán Y; Lazóriga-Sandoval LD; Cruz-Vilcarromero NL; Cubas-Sagardia CR BMC Public Health; 2023 Mar; 23(1):497. PubMed ID: 36922774 [TBL] [Abstract][Full Text] [Related]
39. Healthcare costs associated with antiretroviral adherence among medicaid patients. Pruitt Z; Robst J; Langland-Orban B; Brooks RG Appl Health Econ Health Policy; 2015 Feb; 13(1):69-80. PubMed ID: 25403718 [TBL] [Abstract][Full Text] [Related]
40. Narratives of Ugandan women adhering to HIV/AIDS medication. Matovu SN; La cour K; Hemmingsson H Occup Ther Int; 2012 Dec; 19(4):176-84. PubMed ID: 22740312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]